Technology | 2021.03.03
FARAPULSE's Pivotal ADVENT Trial underway with First Patients Treated with its Breakthrough Pulsed Field Ablation System to Treat Atrial Fibrillation
Pioneering technology has demonstrated potential to improve safety for patients with paroxysmal atrial fibrillation and simplify procedures for physicians MENLO PARK, Calif., March 3, 2021 /PRNewswire/ - FARAPULSE Inc. today announced the first patients were treated in the ADVENT Trial, a...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]al-fibrillation-301239489.html
